Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Aethlon Medical (AEMD) Shares Repurchased (2016 - 2018)

Aethlon Medical filings provide 3 years of Shares Repurchased readings, the most recent being $32737.0 for Q2 2018.

  • On a quarterly basis, Shares Repurchased fell 75.95% to $32737.0 in Q2 2018 year-over-year; TTM through Jun 2018 was $175241.0, a 65.95% decrease, with the full-year FY2019 number at $193866.0, down 30.42% from a year prior.
  • Shares Repurchased hit $32737.0 in Q2 2018 for Aethlon Medical, down from $80106.0 in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $306525.0 in Q1 2017 to a low of $4650.0 in Q4 2016.
  • Median Shares Repurchased over the past 3 years was $51354.5 (2016), compared with a mean of $86236.0.
  • Biggest five-year swings in Shares Repurchased: surged 660.56% in 2017 and later tumbled 75.95% in 2018.
  • Aethlon Medical's Shares Repurchased stood at $4650.0 in 2016, then surged by 660.56% to $35366.0 in 2017, then decreased by 7.43% to $32737.0 in 2018.
  • The last three reported values for Shares Repurchased were $32737.0 (Q2 2018), $80106.0 (Q1 2018), and $35366.0 (Q4 2017) per Business Quant data.